San Luis Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-9,885
Closed -$913K 145
2024
Q4
$913K Buy
9,885
+319
+3% +$28.7K 0.17% 58
2024
Q3
$802K Buy
9,566
+4,557
+91% +$348K 0.17% 57
2024
Q2
$344K Buy
+5,009
New +$334K 0.08% 91
2022
Q2
Sell
-3,728
Closed -$271K 216
2022
Q1
$271K Buy
+3,728
New +$238K 0.13% 126
2021
Q4
Sell
-4,108
Closed -$287K 108
2021
Q3
$287K Buy
+4,108
New +$289K 0.16% 126
2020
Q4
$514K Buy
+8,816
New +$532K 0.33% 79

Other funds holding GILD

San Luis Wealth Advisors's GILD Position: Q1 2025 in Review

San Luis Wealth Advisors sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 9,885 shares — an estimated $913K sold.

San Luis Wealth Advisors first reported a position in GILD in Q4 2020 and held it in 6 quarters. The position peaked at $913K in Q4 2024. 2,013 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

  • San Luis Wealth Advisors reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
  • San Luis Wealth Advisors sold 9,885 Gilead Sciences shares in Q1 2025, an estimated $913K.
  • San Luis Wealth Advisors first reported a position in Gilead Sciences in Q4 2020 and held it in 6 quarters.
  • San Luis Wealth Advisors's Gilead Sciences position peaked at $913K in Q4 2024.
  • 2,013 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on San Luis Wealth Advisors's 13F filing for Q1 2025, filed 15 Apr 2025.